|
Modified PCR-RFLP for detection of JAK2V617F mutation in patients with myeloproliferative neoplasm
|
A.R. Moradabadi   , A.R. Farsinejad , A. Fatemi |
|
|
| Keywords: Key words: Myeloproliferative Disorders, PCR, Neoplasm, Philadelphia Chromosome |
|
|
Full-Text [PDF 430 kb]
(2387 Downloads)
| Abstract (HTML) (4551 Views)
|
Type of Study: Research |
Subject:
Hematology
Published: 2017/12/30
|
|
|
|
|
|
|
Full-Text: (2359 Views) |
References:
- Neoplasm M. International Journal of Biological & Medical Research. Int J Biol Med Res 2012; 3(2): 1801-5.
- Trifa AP, Popp RA, Cucuianu A, Dima D, Militaru MS, Paţiu M, et al. JAK2 p.V617F mutation–tetra-primer PCR and PCR-RFLP comparative semiquantitative approaches for estimation of the mutant allele in myeloproliferative neoplasms. Revista Română de Medicină de Laborator 2009; 14(1): 25-30.
- James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434(7037): 1144-8
- Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365(9464): 1054-61.
- Zhao R, Xing S, Li Z, Fu X, Li Q, Krantz SB, et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem 2005; 280(24): 22788-92.
- Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G,
Huntly BJ, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7(4): 387-97.
- Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352(17): 1779-90.
- Er TK, Lin SF, Chang JG, Hsieh LL, Lin SK, Wang LH, et al. Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation. Clin Chim Acta 2009; 408(1-2): 39-44.
- Cao HC, Lin J, Qian J, Yao DM, Li Y, Yang J, et al. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis. J Clin Lab Anal 2011; 25(4): 300-4.
- Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106(6): 2162-8.
|
Sci J Iran Blood Transfus Organ 2018; 14(4): 289-294
|
Modified PCR-RFLP for detection of JAK2V617F
mutation in patients with myeloproliferative neoplasm
Moradabadi A.R.1, Farsinejad A.R.2, Fatemi A.2
1Student Research Committee, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran
2Department of Hematology, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background and Objectives
Chronic myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders. They are heterogeneous in symptoms and mainly consist of Philadelphia chromosome positive (Ph+) and negative (Ph-). The Ph- group includes polycythemia Vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF) and other rare disorders. In the latter group, substitution of phenylalanine for valine at codon 617 (JAK2V617F), could be relevant to the disease. In this study we used modified PCR-RFLP to detect JAK2 V617 F mutation in chronic myeloproliferative neoplasms.
Materials and Methods
In this cross sectional study, for detection of JAK2 V617 F mutation, 47 subjects were enrolled and peripheral blood samples were collected between 2015 and 2016. The samples were collected from the clinic center of Arak city and diagnosed to be JAK2 V617F positive by TaqMan probe and sequencing methods. All samples were investigated for the mutation by modified PCR-RFLP using specific primers and BsaXI restriction enzyme. The data were analyzed by t-test.
Results
Our modified PCR-RFLP for detection of JAK2 V617F mutation showed the same results as TaqMan probe and sequencing standard methods. In this study we have positive and negative samples and a standard method whose sensitivity and specificity was calculated to be 100% .
Conclusions
Our modified PCR-RFLP is a comparable method with gold standard methods, TaqMan probe and sequencing, for detection of JAK2 V617F mutation. The advantages of this modified method include its ability to detect JAK2 V617F in homozygote and heterozygote conditions, and the presence of the internal digestion control.
Key words: Myeloproliferative Disorders, PCR, Neoplasm, Philadelphia Chromosome
Received: 7 Dec 2016
Accepted: 8 Oct 2017
Correspondence: Fatemi A., PhD of Hematology & Blood Banking. Assistant Professor of Department of Hematology, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences.
Postal Code: 7619794435, Kerman, Iran. Tel: (+9834) 32112007; Fax: (+9834) 31325375
E-mail:
ahmad.fatemi2@gmail.com
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Moradabadi A, Farsinejad A, Fatemi A. Modified PCR-RFLP for detection of JAK2V617F mutation in patients with myeloproliferative neoplasm. Sci J Iran Blood Transfus Organ 2017; 14 (4) :289-294 URL: http://bloodjournal.ir/article-1-1093-en.html
|
.jpg)
.png)
